Journal of radiological science and technology (대한방사선기술학회지:방사선기술과학)

Korean Society of Radiological Science (대한방사선과학회)
권호 표지
DOI QR코드

DOI QR Code

The Effect of Volume Reduction on Computed Treatment Planning during Head and Neck IMRT and VMAT

두경부 IMRT 및 VMAT 시 체적 감소가 전산화치료계획에 미치는 영향

  • Ki-Cheon Um (Department of Radiation Oncology, Asan Medical Center) ;
  • Gha-Jung Kim (Department of Radiological Science, Far East University) ;
  • Geum-Mun Back (Department of Radiation Oncology, Asan Medical Center)
  • 엄기천 (서울아산병원 방사선종양학과) ;
  • 김가중 (극동대학교 방사선학과) ;
  • 백금문 (서울아산병원 방사선종양학과)
  • Received : 2023.04.17
  • Accepted : 2023.05.26
  • Published : 2023.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

In this study, we assessed the effect of reduction of tumor volume in the head and neck cancer by using RANDO phantom in Static Intensity-Modulated Radiation Therapy (S-IMRT) and Volumetric-Modulated Arc Therapy (VMAT) planning. RANDO phantom's body and protruding volumes were delineated by using Contour menu of Eclipse™ (Varian Medical System, Inc., Version 15.6, USA) treatment planning system. Inner margins of 2 mm to 10 mm from protruding volumes of the reference were applied to generate the parameters of reduced volume. In addition, target volume and Organ at Risk (OAR) volumes were delineated. S-IMRT plan and VMAT plan were designed in reference. These plans were assigned in the reduced volumes and dose was calculated in reduced volumes using preset Monitor unit (MU). Dose Volume Histogram (DVH) was generated to evaluate treatment planning. Conformity Index (CI) and R2 in reference S-IMRT were 0.983 and 0.015, respectively. There was no significant relationship between CI and the reduced volume. Homogeneity Index (HI) and R2 were 0.092 and 0.960, respectively. The HI increased when volume reduced. In reference VMAT, CI and R2 were 0.992 and 0.259, respectively. There was no relationship between the volume reduction and CI. On the other hand, HI and R2 were 0.078 and 0.895, respectively. The value of HI increased when the volume reduced. There was significant difference (p<0.05) between parameters (Dmean and Dmax) of normal organs of S-IMRT and VMAT except brain stem. Volume reduction affected the CI, HI and OAR dose. In the future, additional studies are necessary to incorporate the reduction of the volume in the clinical setting.

Keywords

References

  1. Chin D, Boyle GM, Porceddu S, et al. Head and neck cancer: Past, present and future. Expert Review of Anticancer Therapy. 2006;6(7):1111-8. https://doi.org/10.1586/14737140.6.7.1111
  2. Scottish Intercollegiate Guideline Network. Diagnosis and management of head and neck cancer: A national clinical guideline. 2006:50-1. [cited 2009 Apr 23]. Available from: http://www.sign.ac.uk/pdf/sign90.pdf
  3. Hurria A, Togawa K, Mohile SG, et al. Predicting chemotherapy toxicity in older adults with cancer: A prospective multicenter study. Journal of Clinical Oncology. 2011;29(25):3457-65. https://doi.org/10.1200/JCO.2011.34.7625
  4. Ravasco P, Monteiro-Grillo I, Vida PM, et al. Impact of nutrition on outcome: A prospective randomized controller trial in patients with head and neck cancer undergoing radiotherapy. Journal of the Sciences and Specialties of the Head and Neck. 2005;27(8):659-68. https://doi.org/10.1002/hed.20221
  5. Winqiust E, Oliver T, Gibert R. Postoperative chemoradiotherpapy for advanced squamous cell carcinoma of the head and neck: A systemic review with meta-analysis. Journal of the Head and Specialties of the Head and Neck. 2007;29(1):38-46. https://doi.org/10.1002/hed.20465
  6. Lees J. Incidence of weight loss in head and neck cancer patients on commencing radiotherapy treatment at a regional oncology centre. Eur J Cancer Care(Engl). 1999;8(3):133-6. https://doi.org/10.1046/j.1365-2354.1999.00156.x
  7. Vangelov B, Venchiarutti RL, Smee RI. Critical weight loss in patients with oropharynx cancer during radiotherpay (± Chemotherapy). Nutrition and Cancer. 2017;69(8):1211-8. https://doi.org/10.1080/01635581.2017.1367943
  8. Seo SJ, Kim TW, Choi MH, et al. Evaluate the change of body shape and the patient alignement state during image-guided volumetric modulated arc therapy in head and neck cancer patients. KOSRT. 2017;29(2):109-17.
  9. Zhang L, Wang Z, Shi C, et al. The impact of robustness of deformable image registration on contour propagation and dose accumulation for head and neck adaptive radiotherapy. J Appl Clin Med Phys. 2018;19(4):185-94. https://doi.org/10.1002/acm2.12361
  10. Oh S, Kim S. Deformable image registration in radiation therapy. Radiat Oncol J. 2017;35(2):101-11. https://doi.org/10.3857/roj.2017.00325
  11. Nie K, Pouliot J, Smith E, et al. Performance variations among clinically available deformable image registration tools in adaptive radiotherpay-How should we evaluate and interpret the result? J Appl Cin Med Phys. 2016;17(2):328-40.
  12. Kwon KT, Min JW. Comparison of doses according to change of bladder volume in treatment of prostate cancer. Journal of Radiological Science and Technology. 2017;40(3):415-21. https://doi.org/10.17946/JRST.2017.40.3.09
  13. ICRU. Prescribing, recording, and reporting photon beam therapy (Supplement to ICRU Report 50). International Commission on Radiation Units and Measurements (ICRU). Report 62: Journal of the ICRU. 2007;7(2):Report 62.
  14. Feuvret L, Noel G, Mazeron JJ, et al. Conformity index: A review. Int J Radiat Oncol Biol Phys. 2006;64(2):333-42. https://doi.org/10.1016/j.ijrobp.2005.09.028
  15. Kang DJ, Jung JY, Shin YJ, et al. Evaluation of dose volume and radiobiological indices by the dose calculation grid size in nasopharyngeal cancer VMAT. Journal of Radiological Science and Technology. 2020;43(4):265-72. https://doi.org/10.17946/JRST.2020.43.4.265
  16. Garden AS, Dong L, Morrison WH, et al. Patterns of disease recurrence following treatment of oropharyngeal cancer with intensity modulated radiation therapy. International Journal of Radiation Oncology Biology Physics. 2013;85(4):941-7. https://doi.org/10.1016/j.ijrobp.2012.08.004
  17. Lee N, Harris J, Garden AS, et al. Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: Radiation therapy oncology group phase II trial 0225. H Clin Oncol. 2009;27(22):3684-90. https://doi.org/10.1200/JCO.2008.19.9109